Richard Rapoza

Industry (incl. R&D)

ABBOTT VASCULAR - Santa Clara, United States of America

Latest contributions

Artificial intelligence (AI) in interventional cardiology

16 May 2024 – From EuroPCR 2024

Watch this discussion with Jan McCloud, Bram Van Ginneken, Niels Van Royen, and Richard Rapoza as they distinguish between artificial intelligence (AI) and machine learning, explore AI's impact on interventional cardiology, and Abbott's integration of AI. They also delve into AI's challenges, including algorithm development complexities...